RJA
CMD

Raymond James & Associates’s Cantel Medical Corporation CMD Stock Holding History

Raymond James & Associates’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-8,046
Closed -$635K – 4159
2020
Q4 		$635K Buy
8,046
+2,780
+53% +$163K ﹤0.01% 2648
2020
Q3 		$231K Buy
+5,266
New +$259K ﹤0.01% 3116
2020
Q2 		– Sell
-46,005
Closed -$1.65M – 3703
2020
Q1 		$1.65M Buy
46,005
+13,230
+40% +$752K ﹤0.01% 1683
2019
Q4 		$2.32M Buy
32,775
+24,217
+283% +$1.76M ﹤0.01% 1738
2019
Q3 		$640K Buy
8,558
+4,707
+122% +$399K ﹤0.01% 2489
2019
Q2 		$311K Buy
3,851
+486
+14% +$34.2K ﹤0.01% 2995
2019
Q1 		$225K Buy
3,365
+228
+7% +$17.3K ﹤0.01% 3171
2018
Q4 		$234K Sell
3,137
-487
-13% -$40.2K ﹤0.01% 3018
2018
Q3 		$334K Sell
3,624
-1,006
-22% -$95.8K ﹤0.01% 2961
2018
Q2 		$455K Buy
4,630
+1,192
+35% +$133K ﹤0.01% 2745
2018
Q1 		$383K Buy
3,438
+466
+16% +$52.2K ﹤0.01% 2734
2017
Q4 		$306K Buy
2,972
+381
+15% +$38K ﹤0.01% 2824
2017
Q3 		$244K Buy
+2,591
New +$205K ﹤0.01% 2920
2016
Q3 		– Sell
-2,962
Closed -$204K – 3329
2016
Q2 		$204K Sell
2,962
-592
-17% -$40.8K ﹤0.01% 2646
2016
Q1 		$254K Buy
+3,554
New +$223K ﹤0.01% 2446
2015
Q2 		– Sell
-23,919
Closed -$1.14M – 2472
2015
Q1 		$1.14M Sell
23,919
-2,676
-10% -$118K 0.01% 1585
2014
Q4 		$1.15M Buy
+26,595
New +$1.09M 0.01% 1486

Other funds holding CMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
LGP
Leonard Green & Partners Los Angeles, California $2.77B AUM 3.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Raymond James & Associates's CMD Position: Q1 2021 in Review

Raymond James & Associates sold out of Cantel Medical Corporation (CMD) in Q1 2021, closing a stake of 8,046 shares — an estimated $635K sold.

Raymond James & Associates first reported a position in CMD in Q4 2014 and held it in 17 quarters. The position peaked at $2.32M in Q4 2019. 234 funds tracked by Wall St. Rank hold CMD as of Q1 2021.

  • Raymond James & Associates reported no remaining Cantel Medical Corporation position as of Q1 2021 after selling out during the quarter.
  • Raymond James & Associates sold 8,046 Cantel Medical Corporation shares in Q1 2021, an estimated $635K.
  • Raymond James & Associates first reported a position in Cantel Medical Corporation in Q4 2014 and held it in 17 quarters.
  • Raymond James & Associates's Cantel Medical Corporation position peaked at $2.32M in Q4 2019.
  • 234 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q1 2021.

Based on Raymond James & Associates's 13F filing for Q1 2021, filed 14 May 2021.